Cancer is a global
healthcare challenge; the healthcare industry is witnessing rapid new developments, improved point-of-care diagnostics, cost-effective treatment modalities
and personalized medicine, which not only offer efficient early diagnosis but also treat cancer conditions in order to reduce the healthcare cost and disease
For some time now, healthcare exchanges have
figured prominently in the media. Their central role in the Affordable Care Act, the challenges experienced during initial launch and the intense focus on
signup numbers have all received extensive coverage. But what has been less widely reported is the fact that the concept of online exchanges as a mechanism
to improve healthcare isn’t new.
Striking a balance between the needs of the scientific process in health
sciences research and the legitimate desires of ailing patients is a difficult thing. Whether or not we can or should change the system, we should still
consider the toll it can take on people
Infectious diseases are
a constant and evolving threat, but research into antibiotics is an area of anti-infective research that has seen a lot of drop-off in terms of Big Pharma
interest over the years. Researchers and the public alike may need to open their eyes wider with regard to the dangers of modern bacteria.